Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo
about
Tumors of the neural crest: Common themes in development and cancerEndothelial protein C receptor function in murine and human breast cancer developmentCD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cellsIntegration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.Gene expression and adaptive noncoding changes during human evolution.Characterization of murine pituitary-derived cell lines Tpit/F1, Tpit/E and TtT/GF.Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanomaA multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastomaDevelopment of a prognostic model for breast cancer survival in an open challenge environment.Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traitsValidation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma.Biomolecular events in cancer revealed by attractor metagenes.Role of the protein C receptor in cancer progression.Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinomaMolecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.Dysregulation of astrocyte extracellular signaling in Costello syndrome.Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasisBasal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer.Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumCYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion.Tumor matrix protein collagen XIα1 in cancer.COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance.Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma.Rebooting the collagen gel: Artificial hydrogels for the study of epithelial mesenchymal transformation.
P2860
Q26864763-252F69D8-9979-4E0D-8024-9B80FCD234C6Q27327182-3789C186-DD54-4094-B895-D685292EFBEAQ27329081-4013C078-9DEF-4F54-9CDE-6ACE6202F282Q31034941-9D215D7D-9511-4B6A-84A2-5C8B8590B0C6Q33646231-6EDAE667-E3CF-4FB5-AEB5-293C7BC172A6Q33768288-E9D31D54-4E9A-4733-8737-46E4D8D0F7D9Q34071373-D0F74EC2-1BB1-4710-8918-0D4F0E4B8CF5Q34221697-3080034F-EF3F-439F-A20F-76722D1E0E73Q34228481-034C8B9B-01ED-44E9-BAE5-1E68F6235D12Q34340016-C96B9C7C-6B72-4A8A-B78A-AD6025492822Q34516879-F297862E-CD9F-42AF-8069-85B807FD5DB3Q34518394-B35D1480-DD88-4ABA-BF43-55AEAA162899Q34581858-DEDB1948-A328-42A5-B925-EFE46D63F807Q34611062-A0ACE50F-7960-43BD-9F67-79B21D504078Q34731385-D8621AB8-B52B-40DD-965B-80F1C4D62302Q35103273-58C3D274-E4BF-4300-A5B5-D253C628367DQ35618225-9C5748FD-F1F5-4F76-85CD-8FB67FF22616Q35760763-715982C6-5B10-428E-9915-DBC2181679CFQ35793752-06B1D971-318F-441D-837D-9055FFB95A7CQ36003843-B9C4B229-E747-4C04-A46A-A50E1EB1F291Q36067765-62513B52-3E1B-4D56-B88F-4D7812792F4BQ36079057-81EA25A5-FE48-464C-9860-947B90E24B8FQ36618624-70421137-248B-44D3-9FEF-35FF60AF6162Q36869918-7E0BC948-4B39-4CD6-9910-DE65C1A20D6DQ37261166-0010F9D9-A45A-4198-A772-9DE914A43354Q37307937-508C26A6-1C96-4FBC-8ADB-BE723EEDDCB8Q37327755-A96D04CB-F5BC-4F3F-A7C4-9A9604424165Q37385223-235B16EC-C35B-41F2-BC6F-8A2B4A26FF0BQ38289649-F5EB1CA3-E307-4750-9F08-F056EEB72A3AQ38374291-103FEDE6-60A4-4BA5-83F8-701429BDA903Q38635932-71C6B872-6881-4657-8057-79A4996A29E7Q38763516-A2D572AE-FD29-45EE-962A-9B63BAD4DDECQ38821010-FC944E49-7259-44A7-A5F6-BE86B8912D2AQ38947391-DCD4ACB8-FE56-4990-A942-E345B4C8DF9DQ39395473-68EA4F59-C1C4-4F72-960C-D4256D62973BQ42572358-10707C6C-26FA-49EB-8FEB-FC8908214367Q46890724-16B5BB9B-0EDB-4410-ACFD-25A43719127AQ46961600-C6AFE59E-D96D-499D-A529-AFC05F91933CQ47098609-F112B8DE-E8DB-4AB8-9247-EF900BBD0D36Q48275651-C51BF9B2-2B4B-49F7-ABED-A8551C066A8E
P2860
Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human cancer cells express Slu ...... ion signature obtained in vivo
@ast
Human cancer cells express Slu ...... ion signature obtained in vivo
@en
Human cancer cells express Slu ...... ion signature obtained in vivo
@nl
type
label
Human cancer cells express Slu ...... ion signature obtained in vivo
@ast
Human cancer cells express Slu ...... ion signature obtained in vivo
@en
Human cancer cells express Slu ...... ion signature obtained in vivo
@nl
prefLabel
Human cancer cells express Slu ...... ion signature obtained in vivo
@ast
Human cancer cells express Slu ...... ion signature obtained in vivo
@en
Human cancer cells express Slu ...... ion signature obtained in vivo
@nl
P2093
P2860
P356
P1433
P1476
Human cancer cells express Slu ...... ion signature obtained in vivo
@en
P2093
Darrell J Yamashiro
Dimitris Anastassiou
Jessica J Kandel
Jianzhong Huang
Peter D Canoll
Viktoria Rumjantseva
Weiyi Cheng
P2860
P2888
P356
10.1186/1471-2407-11-529
P407
P577
2011-12-30T00:00:00Z
P5875
P6179
1028267348